🇺🇸 FDA
Patent

US 6251871

P16 expression constructs and their application in cancer therapy

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6251871 (P16 expression constructs and their application in cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P35/00